Education
About Us
Working with TipRanks
Follow Us
Praxis Precision Medicines (PRAX)
NASDAQ:PRAX
Total Valuation
Praxis Precision Medicines has a market cap or net worth of $8.63B. The enterprise value is $6.19B.
Market Cap$8.63B
Enterprise Value$6.19B
Share Statistics
Praxis Precision Medicines has 27,850,834 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding27,850,834
Owned by Insiders18.01%
Owned by Institutions2.01%
Financial Efficiency
Praxis Precision Medicines’s return on equity (ROE) is -0.35 and return on invested capital (ROIC) is -37.14%.
Return on Equity (ROE)-0.35
Return on Assets (ROA)-0.32
Return on Invested Capital (ROIC)-37.14%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee0.00
Profits Per Employee-2.61M
Employee Count116
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Praxis Precision Medicines is ―. Praxis Precision Medicines’s PEG ratio is -0.68.
PE Ratio―
PS Ratio0.00
PB Ratio7.55
Price to Fair Value7.55
Price to FCF-26.63
Price to Operating Cash Flow-27.97
PEG Ratio-0.68
Income Statement
In the last 12 months, Praxis Precision Medicines had revenue of 0.00 and earned -303.27M in profits. Earnings per share was -13.48.
Revenue0.00
Gross Profit-140.00K
Operating Income-326.20M
Pretax Income-303.27M
Net Income-303.27M
EBITDA-303.13M
Earnings Per Share (EPS)-13.48
Cash Flow
In the last 12 months, operating cash flow was -249.38M and capital expenditures -120.00K, giving a free cash flow of -249.50M billion.
Operating Cash Flow-249.38M
Free Cash Flow-249.50M
Free Cash Flow per Share-8.96
Dividends & Yields
Praxis Precision Medicines pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.09
52-Week Price Change724.23%
50-Day Moving Average311.13
200-Day Moving Average152.51
Relative Strength Index (RSI)44.25
Average Volume (3m)438.61K
Important Dates
Praxis Precision Medicines upcoming earnings date is May 13, 2026, Before Open (Confirmed).
Last Earnings DateFeb 19, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
Praxis Precision Medicines as a current ratio of 10.22, with Debt / Equity ratio of 0.01%
Current Ratio10.22
Quick Ratio10.22
Debt to Market Cap<0.01
Net Debt to EBITDA1.18
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Praxis Precision Medicines has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Praxis Precision Medicines EV to EBITDA ratio is -20.70, with an EV/FCF ratio of -25.19.
EV to Sales0.00
EV to EBITDA-20.70
EV to Free Cash Flow-25.19
EV to Operating Cash Flow-25.20
Balance Sheet
Praxis Precision Medicines has $599.33M in cash and marketable securities with $110.00K in debt, giving a net cash position of $599.22M billion.
Cash & Marketable Securities$599.33M
Total Debt$110.00K
Net Cash$599.22M
Net Cash Per Share$21.52
Tangible Book Value Per Share$39.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Praxis Precision Medicines is $607.13, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$607.13
Price Target Upside95.91% Upside
Analyst ConsensusStrong Buy
Analyst Count16
Revenue Growth Forecast364.98%
EPS Growth Forecast-25.33%